PSE reporting threshold erased
This article was originally published in The Tan Sheet
Executive Summary
The distribution of all amounts of pseudoephedrine and phenylpropanolamine fall under the Drug Enforcement Administration's enforcement, according to a final rule published July 7 in the Federal Register. The rule, which takes effect Aug. 6, is the latest step in DEA's implementation of the Combat Methamphetamine Epidemic Act. It eliminates the current threshold of 2.2 pounds to trigger DEA's reporting and recordkeeping requirements, according to a July 7 Federal Register notice. DEA says the unregulated distribution of any amount of PSE increases the likelihood the substance could be diverted to use for illicit meth manufacturing. DEA also imposed retail sales limits and tracking requirements under provisions of Combat Meth (1"The Tan Sheet" Nov. 26, 2007)
You may also be interested in...
Distributions Of All Amounts Of PSE Would Be Regulated Under DEA Rule
The Drug Enforcement Administration continues developing enforcement tools to implement the Combat Meth Act with a Nov. 20 notice of proposed rulemaking to regulate the distribution of all amounts of pseudoephedrine and phenylpropanolamine
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.